Insuman Basal

Insuman Basal: description, manufacturers and dosage forms

Insuman Basal is one of the types of insulin that belongs to the group of medium-acting insulins. It is used to treat diabetes in adults and children. Insuman Basal is produced by Hoechst AG in Germany and has the international name Insulin-SrD.

Insuman Basal is available in several dosage forms, including injection suspension 40 units/ml and 100 units/ml. This form of insulin is administered subcutaneously and provides a gradual and long-lasting decrease in blood glucose levels.

Insuman Basal also has several synonyms, such as B-Insulin Berlin-Chemie, Berlinsulin N Basal U-40, Berlinsulin N Basal pen, Biogulin NPH U-100, Biogulin NPH U-40, Biogulin Lente U-40, Brinsulmidi MK, Brinsulmidi Ch, Brinsulmidi ChSP, V-Insulin SC Berlin-Chemie, Depo-Insulin S, Isofan Insulin, Isofan Insuli.

Intermediate-acting insulins, such as Insuman Basal, are usually used in combination with other types of insulin to achieve optimal blood glucose control in patients with diabetes. However, before starting treatment with Insuman Basal, you must consult your doctor and study the instructions for use in detail to avoid possible side effects.

Overall, Insuman Basal is an important medicine for the treatment of diabetes and helps in effective control of blood glucose levels. However, like any other medicine, it must be used only as prescribed by a doctor and in accordance with the instructions for use.